Developing new advanced molecular diagnostic solutions to help patients make better decisionsMBD



  • About Atturos

    A new and fast growing clinical diagnostics company developing molecular diagnostic tests to support better patient decisions

  • Our Team

    A highly experienced team focussed on patient-orientated development and delivery of innovative new molecular diagnostic tests to market

  • OCProDx

    A non-invasive multiplexed protein blood test that reports a key property of prostate cancer by providing a tumour confinement score

  • Our Vision

    To become a leading provider of clinical information by delivering diagnostic tools to fulfil significant unmet patient and healthcare provider needs

  • Read More

  • Read More

  • Read More

  • Read More